HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.

Abstract
Evi1 (ecotropic viral integration site 1) is essential for proliferation of hematopoietic stem cells and implicated in the development of myeloid disorders. Particularly, high Evi1 expression defines one of the largest clusters in acute myeloid leukemia and is significantly associated with extremely poor prognosis. However, mechanistic basis of Evi1-mediated leukemogenesis has not been fully elucidated. Here, we show that Evi1 directly represses phosphatase and tensin homologue deleted on chromosome 10 (PTEN) transcription in the murine bone marrow, which leads to activation of AKT/mammalian target of rapamycin (mTOR) signaling. In a murine bone marrow transplantation model, Evi1 leukemia showed modestly increased sensitivity to an mTOR inhibitor rapamycin. Furthermore, we found that Evi1 binds to several polycomb group proteins and recruits polycomb repressive complexes for PTEN down-regulation, which shows a novel epigenetic mechanism of AKT/mTOR activation in leukemia. Expression analyses and ChIPassays with human samples indicate that our findings in mice models are recapitulated in human leukemic cells. Dependence of Evi1-expressing leukemic cells on AKT/mTOR signaling provides the first example of targeted therapeutic modalities that suppress the leukemogenic activity of Evi1. The PTEN/AKT/mTOR signaling pathway and the Evi1-polycomb interaction can be promising therapeutic targets for leukemia with activated Evi1.
AuthorsAkihide Yoshimi, Susumu Goyama, Naoko Watanabe-Okochi, Yumiko Yoshiki, Yasuhito Nannya, Eriko Nitta, Shunya Arai, Tomohiko Sato, Munetake Shimabe, Masahiro Nakagawa, Yoichi Imai, Toshio Kitamura, Mineo Kurokawa
JournalBlood (Blood) Vol. 117 Issue 13 Pg. 3617-28 (Mar 31 2011) ISSN: 1528-0020 [Electronic] United States
PMID21289308 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • MDS1 and EVI1 Complex Locus Protein
  • MECOM protein, human
  • Polycomb-Group Proteins
  • Repressor Proteins
  • Transcription Factors
  • MTOR protein, human
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • PTEN Phosphohydrolase
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Cells, Cultured
  • DNA-Binding Proteins (metabolism, physiology)
  • Down-Regulation (genetics)
  • Female
  • Gene Expression Regulation, Leukemic
  • Humans
  • Leukemia (genetics, metabolism, pathology)
  • MDS1 and EVI1 Complex Locus Protein
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Middle Aged
  • Models, Biological
  • PTEN Phosphohydrolase (genetics, metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Polycomb-Group Proteins
  • Protein Binding
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Proto-Oncogenes (physiology)
  • Repressor Proteins (metabolism)
  • Signal Transduction (genetics)
  • TOR Serine-Threonine Kinases (metabolism)
  • Transcription Factors (metabolism, physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: